AlphaCrest Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
AlphaCrest Capital Management's MDT Position: Q4 2022 in Review
AlphaCrest Capital Management sold out of Medtronic (MDT) in Q4 2022, closing a stake of 21,826 shares — an estimated $1.76M sold.
AlphaCrest Capital Management first reported a position in MDT in Q4 2018 and held it in 16 quarters. The position peaked at $17.2M in Q4 2021. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- AlphaCrest Capital Management reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
- AlphaCrest Capital Management sold 21,826 Medtronic shares in Q4 2022, an estimated $1.76M.
- AlphaCrest Capital Management first reported a position in Medtronic in Q4 2018 and held it in 16 quarters.
- AlphaCrest Capital Management's Medtronic position peaked at $17.2M in Q4 2021.
- 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on AlphaCrest Capital Management's 13F filing for Q4 2022.